Related Experiment Video
Updated: Jun 3, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Changes in haemostatic and platelet activation markers in non-dipper hypertensive patients
Athanasia Agorasti1, Efthimia Mourvati, Theodoros Trivellas
1Department of Haematology Laboratory, General Hospital of Xanthi, Ephessou 68, 67100 Xanthi, Greece. vhrissan@civil.duth.gr
Insights
Non-dipper hypertensive patients show higher levels of key blood clotting and fibrinolysis markers. These haemostatic alterations in non-dippers may contribute to their increased cardiovascular disease risk.
Area of Science:
- Cardiovascular Medicine
- Hypertension Research
- Hemostasis and Thrombosis
Background:
- Non-dipper hypertension is a recognized risk factor for cardiovascular disease.
- Activation of coagulation and fibrinolysis pathways are implicated in cardiovascular risk.
- Understanding haemostatic differences in non-dippers is crucial for risk stratification.
Purpose of the Study:
- To investigate the relationship between haemostatic and platelet activation markers and the non-dipping blood pressure pattern.
- To compare coagulation and fibrinolysis markers in treated hypertensive patients with and without the non-dipping pattern.
Main Methods:
- Seventy-one treated hypertensive patients were categorized as dippers or non-dippers based on 24-hour ambulatory blood pressure monitoring.
- Plasma levels of coagulation factors (VIII, IX, fibrinogen), activation markers (prothrombin fragment 1+2, thrombin-antithrombin complex), and fibrinolysis markers (protein C, plasmin-alpha-2-antiplasmin complex, D-dimer) were measured.
- Platelet factor 4 was also assessed as a marker of platelet activation.
Main Results:
- Non-dipper hypertensive patients exhibited significantly higher plasma levels of factors VIII and IX, fibrinogen, prothrombin fragment 1+2, protein C, plasmin-alpha-2-antiplasmin complex, and D-dimers compared to dippers.
- No significant differences were observed in thrombin-antithrombin complex or platelet factor 4 levels between the groups.
- These findings indicate widespread alterations in haemostasis among non-dipper hypertensive individuals.
Conclusions:
- Treated hypertensive patients with a non-dipping blood pressure pattern demonstrate significant alterations in haemostatic and fibrinolytic markers.
- These haemostatic changes in non-dippers may contribute to their elevated risk of cardiovascular events.
- Further research is warranted to explore therapeutic strategies targeting these haemostatic pathways in non-dipper hypertension.
Background:
Non-dipper hypertensive patients are at increased risk for cardiovascular disease. Coagulation and fibrinolysis activation factors are considered as risk factors for cardiovascular disease. The aim of this study was to examine the relationship between the haemostatic and platelet activation markers and the non-dipping pattern in treated hypertensive patients.
Patients And Methods:
Seventy-one treated hypertensive patients (53 with essential and 18 with secondary hypertension, due to chronic kidney disease-stage 4), aged 33 to 81 years (30 men), were classified as dippers and non-dippers, according to the presence or absence, respectively, of a decline of nocturnal average systolic blood pressure (BP) by more than 10% of the diurnal BP (non-dipping pattern) on 24-hour ambulatory BP monitoring. Plasma levels of factors VIII and IX, fibrinogen, prothrombin fragment 1 + 2, thrombin-antithrombin complex, protein C, plasmin-alpha-2 antiplasmin complex, D-dimer and platelet factor 4 were measured in all patients.
Results:
Thirty-seven patients were classified as dippers and 34 as non-dippers. The percentages of patients with essential and with secondary hypertension were similar in the dippers and in the non-dippers groups (both P = 0.754). Multivariate analysis of variance showed statistically significant differences in all measured variables between dippers and non-dippers (P = 0.043). Plasma levels of factors VIII and IX, fibrinogen, prothrombin fragment 1 + 2, protein C, plasmin-alpha-2-antiplasmin complex, and D-dimers were significantly higher in non-dippers when compared to dippers (P < 0.05 for all). In contrast, there were no significant differences in plasma levels of thrombin-antithrombin complex (P = 0.955) and platelet factor 4 (P = 0.431) between the two groups.
Conclusion:
This study provides evidence that non-dipper treated hypertensive patients exhibit alterations in haemostasis, which may affect their cardiovascular risk.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension and Regulation of Blood Pressure
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Hypertension I: Introduction

